Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
Abstract Background The long-term outcomes of Ulcerative colitis (UC) after discontinuation of biological therapy are largely unknown. There is also a lack of accurate and validated markers that can predict outcome after withdrawal accurately. The aims of this study were to describe the long-term ou...
Main Authors: | Kay-Martin Johnsen, Jon Florholmen, Øystein K. Moe, Mona Gundersen, Julia Beilfuss, Hege Kileng, Sveinung W. Sørbye, Rasmus Goll |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02522-4 |
Similar Items
-
Intensified anti-TNF treatment downregulates the phenotype in ulcerative colitis: a 13-year prospective follow-up study
by: Jon Florholmen, et al.
Published: (2024-01-01) -
Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?
by: Guanglin Cui, et al.
Published: (2022-05-01) -
Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease
by: Rasmus Goll, et al.
Published: (2022-11-01) -
Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
by: Jon R. Florholmen, et al.
Published: (2020-10-01) -
Real-life evaluation of histologic scores for Ulcerative Colitis in remission.
by: Christian Børde Arkteg, et al.
Published: (2021-01-01)